Banner - Collaborative Care Symposium
News
All NewsContributorsMoney Matters
Media
All VideosExpert InterviewsMedical World NewsPodcastsCase Based Roundtable SeriesCase of the QuarterEyeViewGrand RoundsInsightsRapid ReadoutViewpointsWhat’s Your WhEYE?
Conferences
Conference CoverageConference Listing
Events
More
Publications
Digital EditionEurope Ophthalmology TimesModern RetinaSupplements and Featured Publications
CME
Partners
Resources
Job BoardSponsored

Subscribe

  • News
  • Media
  • Conferences
  • Events
  • Publications
  • CME
  • Partners
  • Subscribe
  • Resources
  • AMD
  • Biosimilars
  • COVID-19
  • Cataract
    • Cataract Surgery
  • Cataract Therapeutics
  • Clinical Diagnosis
    • The Residency Report
    • iOpeners
    • NeuroOp Guru
  • Cornea
  • DME
  • Dry Eye
    • Dry Eye Awareness
  • Gene Therapy
  • Geographic Atrophy
  • IOL
    • IOL Advances
  • Imaging
  • Interventional Glaucoma
    • Glaucoma Awareness
    • Glaucoma Insights
    • Therapeutic Glaucoma
  • OCT
  • Ocular Allergy
  • Ocular Surface Disease
  • Optic Relief
  • Optometry
  • Pediatrics
  • Pharmacy
  • Practice Management
    • Indispensable
  • Presbyopia
  • Ptosis
  • Refractive
    • Refractive Surgery
  • Retina
  • Surgery
  • Technology
  • Therapeutics
  • Understanding Antibiotic Resistance
  • Workplace
Spotlight -
Retina
Advertisement

David Szanto, BA

Advertisement

Articles by David Szanto, BA

Artificial intelligence enhances detection of neuro-ophthalmic disorders

ByDavid Szanto, BA,Asala Erekat, PhD,Brian Woods, MBBCh,Jui-Kai Wang, PhD,Mona Garvin, PhD,Brett A. Johnson, PhD,Randy Kardon, MD, PhD,Edward Linton, MD,Mark J. Kupersmith, MD
June 17th 2025

Deep learning discerns IIH, NAION, and normal eyes using single fundus image.

Advertisement

Latest Updated Articles

  • Artificial intelligence enhances detection of neuro-ophthalmic disorders
    Artificial intelligence enhances detection of neuro-ophthalmic disorders

    Published: June 17th 2025 | Updated:



Advertisement
Advertisement

Trending on Ophthalmology Times - Clinical Insights for Eye Specialists

1

EYDENZELT, Celltrion’s biosimilar referencing EYLEA, approved by FDA

2

Quantifying intermittent retinal capillary perfusion in RVO and PDR

3

Q&A: Inder Paul Singh, MD, explores technician empowerment via the Academy Technician Training Platform

4

AAO 2025: Technician training platform expands education opportunities in ophthalmology

5

Horizon Surgical Systems performs first AI-assisted cataract surgery

  • About
  • Advertise
  • Privacy
  • Editorial Info
  • Editorial Board
  • Terms and Conditions
  • Contact Us
  • Do Not Sell My Personal Information
  • Job Board
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

  • Ophthalmology Times
  • Modern Retina
  • Optometry Times
  • Ophthalmology Times Europe
EyeCare Network
Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us